HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

What is the best approach to the teenage patient presenting with nonclassical congenital adrenal hyperplasia: should we always treat with glucocorticoids?

Abstract
Patients with Congenital adrenal hyperplasia due to partial deficiency in the enzyme 21-hydroxylase can present in childhood or adolescence with signs of adrenal androgen excess. Strategies to reduce the impact of androgen excess in females include cosmetic measures as well as antiandrogens and agents such as the combined oral contraceptive pill. Glucocorticoid may not be appropriate straightaway but can be introduced if other measures are ineffective or when pregnancy is planned.
AuthorsDeborah Matthews, Tim Cheetham
JournalClinical endocrinology (Clin Endocrinol (Oxf)) Vol. 78 Issue 3 Pg. 338-41 (Mar 2013) ISSN: 1365-2265 [Electronic] England
PMID23039910 (Publication Type: Journal Article)
Copyright© 2012 Blackwell Publishing Ltd.
Chemical References
  • Glucocorticoids
  • Steroid 21-Hydroxylase
Topics
  • Adolescent
  • Adrenal Hyperplasia, Congenital (diagnosis, drug therapy, enzymology)
  • Child
  • Female
  • Glucocorticoids (therapeutic use)
  • Humans
  • Steroid 21-Hydroxylase (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: